James V Cassella Concert Pharmaceuticals, Inc. (CNCE) insider trading activity
James V Cassella is Chief Development Officer of CONCERT PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of CNCE, which is worth approximately $0. The most recent transaction as insider was on Mar 06, 2023, when has been sold 80,595 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
0
0%
3M change
0%
12M change
Total Value Held
$0
James V Cassella Transaction History
Also insider at
JVC
James V Cassella
Chief Development Officer
Lexington, MA